Free Trial

Windtree Therapeutics (WINT) Earnings Date, Estimates & Call Transcripts

Windtree Therapeutics logo
$1.00 0.00 (-0.45%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$1.01 +0.02 (+1.76%)
As of 05/2/2025 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Windtree Therapeutics Earnings Summary

Upcoming Q4
Earnings Date
May. 21Before Market OpensEstimated
Consensus EPS
(Nov. 26)
-$113.50
Actual EPS
(Nov. 26)
-$211.50 Missed By -$98.00

Windtree Therapeutics posted Q3 2024 earnings on November 26, 2024, reporting an EPS of -$211.50, which missed the consensus estimate of -$113.50 by $98.00. With a trailing EPS of -$823.47, Windtree Therapeutics' earnings are expected to grow next year, from ($5.66) to ($2.86) per share.

Q3 2024 Earnings Resources

WINT Upcoming Earnings

Windtree Therapeutics' next earnings date is estimated for Wednesday, May 21, 2025, based on past reporting schedules.

Get Windtree Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Windtree Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

WINT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Windtree Therapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate
($5.66) EPS
Next Year EPS Consensus Estimate
($2.86) EPS

Windtree Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/21/2025
(Estimated)
--------
11/26/2024Q3 2024-$113.50-$211.50 -$98.00-$4.23--
8/19/2024--$405.50-$1,045.50 -$640.00-$20.91--
5/15/2024Q4 2023--$462.50 -$462.50-$40.48--
4/16/2024Q4 2023--$665.50 -$665.50-$13.31--
11/9/2023Q3 2023--$774.00 -$774.00-$0.86--
8/7/2023Q2 2023--$1,476.00 -$1,476.00-$1.64--
5/15/2023Q1 2023--$4,284.00 -$4,284.00-$4.76--

Windtree Therapeutics Earnings - Frequently Asked Questions

Windtree Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 21st, 2025 based off last year's report dates. Learn more on WINT's earnings history.

In the previous quarter, Windtree Therapeutics (NASDAQ:WINT) missed the analysts' consensus estimate of ($113.50) by $98.00 with a reported earnings per share (EPS) of ($211.50). Learn more on analysts' earnings estimate vs. WINT's actual earnings.

Windtree Therapeutics (NASDAQ:WINT) has a recorded net income of -$20.29 million. WINT has generated -$823.47 earnings per share over the last four quarters.

Windtree Therapeutics's earnings are expected to grow from ($5.66) per share to ($2.86) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:WINT) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners